Welcome to the Codexis Investor Relations Headquarters
Codexis, Inc. (Nasdaq: CDXS) is a world leader in developing biocatalysts for the pharmaceutical and fine chemical industries. Codexis utilizes its proprietary CodeEvolver® protein engineering technology platform for the discovery, identification, optimization, and efficient production of enzymes for its customers. Customers include global leaders such as GlaxoSmithKline, Merck, Pfizer, and Teva.
Sign up for E-mail Alerts
You may automatically receive Codexis, Inc. information by e-mail
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.